齐鲁医学ICU-导管相关感染调查_第1页
齐鲁医学ICU-导管相关感染调查_第2页
齐鲁医学ICU-导管相关感染调查_第3页
齐鲁医学ICU-导管相关感染调查_第4页
齐鲁医学ICU-导管相关感染调查_第5页
已阅读5页,还剩17页未读 继续免费阅读

下载本文档

版权说明:本文档由用户提供并上传,收益归属内容提供方,若内容存在侵权,请进行举报或认领

文档简介

1、Surveillance ofDevice Related Infection in Intensive Care Unit ICU导管相关感染监测 (A version for training purpose only, the data involved is not reflecting the real situation )2021/10/23 星期六1National Nosocomial Infections Surveillance (NNIS) system全国院内感染监测系统2021/10/23 星期六2Purpose目的Monitor the infection rat

2、es 监控感染率Benchmark with NNIS System 与NNIS标竿Determine trends 确定趋势Identify outbreak 定义暴发Facilitate comparisons 易于比较Link monitored rates and prevention efforts 感染率与预防效果的联系Reduce devices related infection in hospital 减少医院导管等装置的感染率2021/10/23 星期六3Population at risk 危险人群 All patients has been admitted in IC

3、U for 48 hours. 入ICU48小时的病人Follow patients for 48 hours after discharge from ICU. 病人转出ICU 需继续跟踪48小时2021/10/23 星期六4Device-associated infections 导管相关感染Urinary catheter-associated Urinary tract infection (CA-UTI) 导尿管相关的尿路感染Central line- associated Bloodstream infection (CA-BSI) 中心静脉导管相关的血流感染Ventilator-

4、 associated Pneumonia (VAP) 呼吸机相关的肺炎2021/10/23 星期六5Denominator data 分母资料Count at 12 midnight in everyday 每天在午夜12点计算Total number of patients admission 所有病人Patient-days 病人日Urinary catheter-days 导尿管日Central line-days 中心静脉插管日Ventilator-days 呼吸机日2021/10/23 星期六6Surveillance methods 调查方法on going review eac

5、h patient in ICU. 持续观察ICU的每个病人by reviewing Doctors progress notes, Nursing notes, Physiotherapists notes, XR report, charts, MAR forms, conversations with nurses and physicians 查看医生病程、护理记录、理疗单、X线检查、CT/MAR。医生护士的会话by reviewing laboratory data. 查看实验室数据 2021/10/23 星期六72021/10/23 星期六82021/10/23 星期六92021/

6、10/23 星期六10Define device-related infection 定义导管相关感染By using standard CDC definitions that include laboratory & clinical data使用CDC的标准包括实验室和临床资料2021/10/23 星期六11Definitions VAPHad device within 48-hrs period before onset of infection Systemic S/SRespiratory S/SChest X-R evidenceLaboratory results2021/1

7、0/23 星期六12Definitions CA-BSI Had device within 48-hrs period before onset of infectionClinical manifestationsCommon skin contaminant from 2 blood culturesNo apparent source for BSI except the catheter2021/10/23 星期六13Definitions CA-UTI Symptomatic UTIS/S of UTI+ve urine culture =10Asymptomatic bacter

8、iuria+ve urine culture =10No S/S of UTI552021/10/23 星期六14Calculate Device-associated infection ratesNumber of device-associated infection for a specific site x 1000Number of device-days2021/10/23 星期六15Calculate Device utilization ratios Number of device-daysNumber of patient-days2021/10/23 星期六16VAP

9、Surveillance in ICUABNo. of VAP627Patient days13734872Ventilator days 6432694Infection rates9.33 (50)10.02 (50)DU ratios0.47 500.55 75() NNIS device associated infection percentile NNIS device utilization percentile2021/10/23 星期六17CA-BSI Surveillance in ICU ABNo. of CA-BSI 08Patient days13734872CVC

10、days4023216Infection rates0 (10)2.49(25)DU ratios0.26 100.6650() NNIS device associated infection percentile NNIS device utilization percentile2021/10/23 星期六18CA-UTI Surveillance in ICUABNo. of UTI2312Patient days13734872Urinary Cath days11484711Infection rates20.03 (90)2.55(25)DU ratios0.84 500.97.

11、90() NNIS device associated infection percentile NNIS device utilization percentile2021/10/23 星期六19Pathogens Isolated - VAPNo. of infection6No. of isolate9GM -ve microorganism66.6%Proteus, Pseudnmonas, Acinetobacter, Klebsiella, EnterobacterGM +ve microorganism33.3%-haem. Strep., MSSA, Strep. pneumoniaeFungus0%2021/10/23 星期六20Pathogens Isolated CA-UTINo. of infection23No. of isolate28GM -ve microorganism 92.9%E.Coli (50%), Klebsi

温馨提示

  • 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
  • 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
  • 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
  • 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
  • 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
  • 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
  • 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。

评论

0/150

提交评论